Ulrich Bickel

Dr. Ulrich Bickel

orcid

Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2003 in Journal of Controlled Release
Verified
Journal Article
Closed access
KKKlaus Kunath
Klaus Kunath
AHAnke Von Harpe
Anke Von Harpe
DFDagmar Fischer
Dagmar Fischer
HPHolger Petersen
Holger Petersen
UBUlrich Bickel
Ulrich Bickel
TKThomas Kissel
Thomas Kissel

6 May 2002 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
JBJan Born
Jan Born
TLTanja Lange
Tanja Lange
WKWerner Kern
Werner Kern
GMGerard P. McGregor
Gerard P. McGregor
UBUlrich Bickel
Ulrich Bickel
HFHorst L. Fehm
Horst L. Fehm

1 March 2001 in Advanced Drug Delivery Reviews
Verified
Journal Article
Closed access
UBUlrich Bickel
Ulrich Bickel
TYTakayoshi Yoshikawa
Takayoshi Yoshikawa
William PardridgeWilliam Pardridge
William Pardridge

1 March 2000 in The Journal of Pharmacology and Experimental Therapeutics
Verified
Journal Article
Closed access
HLHwa Jeong Lee
Hwa Jeong Lee
BEBritta Engelhardt
Britta Engelhardt
JLJayne Lesley
Jayne Lesley
UBUlrich Bickel
Ulrich Bickel
William PardridgeWilliam Pardridge
William Pardridge

1 November 1992 in Transplantation
Verified
Journal Article
Closed access
HGHans-Joachim Gramm
Hans-Joachim Gramm
HMHarald Meinhold
Harald Meinhold
UBUlrich Bickel
Ulrich Bickel
JZJürgen Zimmermann
Jürgen Zimmermann
BHBirgit Von Hammerstein
Birgit Von Hammerstein
KVKarlheinz Voigt
Karlheinz Voigt
After brain death, 32 potential organ donors were studied to determine serum and plasma concentrations of hypothalamic-pituitary hormones, thyroid hormones, and cortisol over a period of up to 80 hr. Diagnosis of brain death was established either on the basis of clinical criteria (n=16) or by angiography (n=16). While 78% of the organ donors developed diabetes insipidus, none of the circulating hormones of the anterior pituitary gland showed a progressive decline in concentration according to their plasma half-lives. With the exception of arginine vasopressin (AVP), no hormone concentration was found to be subnormal due to the onset of brain death. The subnormal free triiodothyronine (FT3) values in 62% of cases (median FT3 of 2.2 pmol/L within the first 24 hr) and the cortisol concentration of 6.9 μg/dl correlate with the frequency of similar findings in patients with severe head injuries. While the adrenocorticotropic hormone (ACTH) concentrations of 10–53 pg/ml remained constant during the study period, thyroid-stimulating hormone (TSH) and human growth hormone (hGH) concentrations showed a 12− and 35-fold increase from baseline values after 30–40 hr. These results suggest that, despite the now generally accepted criteria of brain death, there is still some residual function, and thus also perfusion of the hypothalamic-pituitary neuroendocrine system. This residual function appears to be sufficient to maintain hormonal plasma levels at least in the low reference range in most donors. Hormonal depletion in organ donors subsequent to brain death, as suggested repeatedly in the literature, could not be confirmed. The analysis of serum or plasma concentration patterns of a number of hormonal parameters following brain death does not support the rationale for a routine replacement therapy of total triiodothyronine (TT3) or cortisol to maintain endocrine homeostasis prior to organ harvest. However, dexamethasone therapy may be followed by suppression of the adrenal cortex of the organ donor. In these cases, cortisol substitution may be indicated.

1 June 2002 in Pharmaceutical Research
Verified
Journal Article
Closed access
PDF file
KKKlaus Kunath
Klaus Kunath
AHAnke von Harpe
Anke von Harpe
HPHolger Petersen
Holger Petersen
DFDagmar Fischer
Dagmar Fischer
KVKarlheinz Voigt
Karlheinz Voigt
UBUlrich Bickel
Ulrich Bickel